ProShares Ultra NASDAQ Biotechnology
36 hedge funds and large institutions have $18.2M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
10
Reduced
7
Closed
6
Calls
$14.5M
Puts
$7.35M
Net Calls
+$7.17M
Net Calls Change
+$3.87M
